ABSTRACT. DNA-dependent protein kinase (DNA-PK), consisting of the 470-kDa catalytic component (DNA-PKcs) and the DNA-binding regulatory component Ku protein (p70/p80), catalyzes phosphorylation of a variety of DNAreplication/transcription/repair factors in the presence of double-stranded DNA.In the resting states of human peripheral blood mononuclear cells, DNA-PKactivity and the protein level of DNA-PKcswere very low in the nuclear extracts, but they were high in the whole cell extracts. Depending upon proliferation of the T lymphocytes, DNA-PKactivity and the protein level of DNA-PKcsin the nuclear extracts greatly increased. Immunocytochemical analysis suggested translocation of DNA-PKcs from the cytoplasm to the nucleus upon growth stimulation in the T lymphocytes.
Double-stranded
DNA-dependent protein serine /threonine kinase (DNA-PK) catalyzes phosphorylation in vitro of a variety of nuclear proteins including SV40 large T antigen, Spl, Fos, Jun, Myc, p53, RP-A, TBP, TFIIB, and the largest subunit of RNApolymerase II (1-9). Minimal essential requirements for the DNA-PK recognition sequence are P-S/T-X and X-S /T-Q (7). The human DNA-PKholoenzyme is composed of the catalytic polypeptide of 470 kDa (DNAPKcs), the DNA-binding Ku protein (p70/p80), and a stimulator double-stranded DNAwith ends or with single-to double-strand transitions (7, (10) (11) (12) (13) . Discovered as an autoimmuneantigen from patients with scleroderma-polymyositis overlap syndrome (14), Ku protein recruits DNAto the DNA-PKcs in relatively low salt conditions (15). These accumulating lines of evidence suggest that DNA-PK is involved in or responsible for DNAreplication, transcription, repair and recombination. DNA-PKhas recently been found to be involved in DNAdouble-strand break repair and V(D)J recombination (16-21), though the molecular details of its involvement in these processes remain to be solved. Little is knowabout the regulation of expression of DNA-PK and the control mechanismof the enzymeactivity. It is known that DNA-PK is reversibly inactivated by autophosphorylation of DNA-PKcs(22). We recently found that non-histone chromosomal high-mobility-group proteins 1 and 2 stimulate DNA-PKactivity in vitro through facilitation of the binding to DNA (23) . In fact, high-mobility-group protein 1 acts as a DNAchaperone such as a . Compared with rodent cells and tissues, the activity level of DNA-PK is 50-to 100-fold higher in cells of human origin including HeLa, Raji and placenta, from which DNA-PK has extensively been purified and characterized (1) (2) (3) 25) . In Raji Burkitt's lymphoma cells, DNA-PKactivity was higher in Gl-arrested states induced by treatment with \.5% dimethyl sulfoxide for 4 days than in the logphase, and a further increase in the enzyme level was observed on reentry into the cell cycle after release from dimethyl sulfoxide (7). The high activity of DNA-PKin the Gl-arrested Raji cells implies that DNA-PKin this malignant cell line may be dysregulated. To verify the expression of DNA-PK in a normal humancell type rather than transformed or immortal cell lines, we employed normal humanT lymphocytes, which are readily obtainable from peripheral blood as a relatively homogenous population of resting cells. NormalhumanT lymphocytes from peripheral blood can be activated to enter the cell cycle by addition of PHAor a combination of PDB and the calcium ionophore ionomycin (26) .
Wedetermined the DNA-PKactivity and the protein levels of DNA-PKcs and Ku protein in human T cells. The activity in the nuclear extracts was low in the resting state and rose 36 to 48 h after the stimulation, concomitant with DNAsynthesis. In the whole cell extracts, however, DNA-PKactivity was high even in rest- Culture conditions and preparation of cells. Heparinized blood was obtained from healthy volunteers. PBMCwere isolated from heparinized peripheral blood by Ficoll-Histopaque density gradient centrifugation. PBMCwere suspended in RPMI 1640 (GIBCO) supplemented with 10% fetal bovine serum. Purified T cells were obtained by the Erosette method, which gives more than 95% purity. Cells (5 x 105-l x 106/ml) were stimulated with 0.25% PHA-P or a combination of 10 nM PDB and 0.5 fiM ionomycin.
pHJThymidine incorporation.
Cells (1 x 105) were transferred to a 96-well round-bottomed microculture plate (Sumitomo Bakelite Co., Tokyo, Japan) and cultured with 0.25% PHA-P or a combination of PDB andionomycin for24, 36, 48 and72 h at 37°C in a5% CO2in-cubator. Cells were pulse-labeled with [3H]thymidine (0.4 /*Ci /well) for the final 2 to 4 h of culture. Cyclosporin (0.1 /^g/ml) and aphidicolin (1 //g/ml) were added at the initiation of cell stimulation.
Demecolcine (0.5 /^g/ml) was added 24 h after stimulation. Cells were then harvested and their radioactivity was counted in a liquid scintillation counter (28).
Flow cytometric analysis of cellular DNAand RNA. Simultaneous analysis of DNAand RNAcontents was performed as described previously (28, 29) . To 0.4 ml of solution containing 0.1% Triton X-100, 0.08 N HC1, 0.15 M NaCl and 0.1 mMEDTA,0.2 ml of culture medium containing 5 x 105 cells was added. After incubation for 1 min on ice, 1.2 ml of a solution containing 37 mMcitric acid, 0.126 M Na2HPO4, 0.15M NaCl, l mMEDTA, and 10//g/ml acridine orange was added. After further incubation at room temperature for 10 min, cells were analyzed in a Cyto-Ace 150 flow cytometer (Japan Spectroscopic Co., Tokyo) with 488 nm excitation. Under the conditions employed, green fluorescence (520-580 nm) was a function of DNAcontent, and red fluorescence (>620 nm) was a function of RNAcontent. Only the DNAhistogram pattern is indicated in Fig. 1 . Preparation of nuclear and whole cell extracts.
Nuclear extracts were obtained as described before (7).
Briefly, cells were harvested and washed twice with ice-cold Buffer A (10mM Hepes-NaOH, pH7.9, 1.5 mM MgCl2, 10 mMKC1, 0.5 mMdithiothreitol, 0. 1 mMphenylmethylsulfonyl fluoride and 1 /*g/ml each of leupeptin, pepstatin A and aprotinin) in a 1.5-ml sample tube. After standing on ice for 10 min in 5 volumes of Buffer A, the cells were homogenized in a Dounce-type homogenizer with 20 strokes, and the homogenate was centrifuged at 15,000 rpm for 15 min in an Eppendorf-type centrifuge. The nuclei from 5 x 106 cells were suspended in 50/il of Buffer B (20mM Tris-HCl, pH7.9, 1.2 mMEDTA, 10% glycerol, 1 mMdithiothreitol, 0.1 mMphenylmethylsulfonyl fluoride and 1 //g/ml each of leupeptin, pepstatin A and aprotinin) containing 0.4 M KC1. After rotation for 30 min at 4°C, the suspension was centrifuged at 15,000 x rpm for 15 min to obtain the nuclear extract. Anequal volume of DEAE-cellulofine equilibrated with Buffer B containing 0.4 M KC1 was added to the extract. After standing for 5 min at 4°C to remove endogenous DNA,the sample was centrifuged at 8,000 rpm for 2 min at 4°C to obtain the supernatant solution. Whole cell extracts were obtained by solubilizing cells direct-ly with Buffer B containing 0.4 MKC1, and then treated with DEAE-cellulofine as in the case of nuclear extracts.
Assay for DNA-PK. The standard assay for DNA-PKwas carried out using the specific synthetic peptide 15, EPPLSQEAFADLWKK (7), as a substrate (4). Briefly, the reaction was carried out at 30°C for 10min in 20-{A of reaction mixture containing 12 mM Hepes-NaOH, pH7.9, 0.6mM EDTA, 0.6mM EGTA, 0.6 mM dithiothreitol, 6% glycerol, 0.012% Tween 20, 50 fM After heating at 95°C for 5min in SDS sample buffer (62.5 mMTris-HC1, pH 6.8, 2% SDS, 10% glycerol and 2% 2-mercaptoethanol), the autophosphorylated products were subjected to electrophoresis on 0.1% SDS/7.5% polyacrylamide gel. The gel wassubjected to silver staining with subsequent autoradiography.
Western blotting/enzyme immunoassay.
The samples were subjected to electrophoresis on 0.1% SDS/7.5% polyacrylamide gel, and then blotted on a nitrocellulose paper. The paper was blocked with 1% bovine serum albumin in 50mM Tris-HCl, pH7.4/0.15 M NaCl/0.05%
Tween 20 (TTBS). The paper was incubated with 10000-fold diluted anti (Ku protein) serum (OM) (15) for one hour, and then with 50000-fold diluted peroxidase-conjugated goat-antibody against human IgG (Sigma) in TTBS containing 1% bovine serum albumin for 30 min. After washing with TTBS, the antigen-antibody complex was visualized with an enhanced chemiluminescence detection kit (Amersham). To detect DNA-PKcs, 5000-fold diluted rabbit anti (DNA-PKcs) antibody and 50000-fold diluted peroxidase-conjugated goat-antibody against rabbit IgG (Sigma) were employed.
Immunocytochemical analysis,
Immunofluorescence studies were performed as described previously (30) . Briefly, cells suspended in PBSwere smeared on a slide glass, dried at room temperature for 1 h, and then fixed in acetone for 3 min. The fixed cells were incubated with either rabbit anti (DNA-PKcs)serum or human anti (Ku protein) serum (OM) at 37°C for 40 min. The slides were washed extensively with PBS, and then incubated with the corresponding FITC-conjugated anti-rabbit F(ab')2 fragment or FITCconjugated anti-human F(ab')2 fragment at 37°C for 40 min. After washing with PBS, the slides were covered and subjected to fluorescence microscopy. RESULTS DNA-PK activity in PHA-activated T cells. Wedetermined DNA-PKactivity in normal human PBMCand purified T cells using a synthetic peptide (peptide 15) as a specific substrate for the enzyme (4). In the resting state of PBMC, which was recognized from cell cycle analysis and [3H]thymidine incorporation, DNA-PK activity in the nuclear extracts was very low (Fig. 1A and B) . Even after stimulation with PHA, which induces proliferation of resting T cells, DNA-PK activity did not increase within 36 h of the stimulation (Fig. IB) . At 48 h, however, a markedly elevated level of the activity was observed, which lasted as long as 72 h (Fig. 1A and B) . This was also the case for purified T cells activated by combined addition of PDB/ionomycin instead of PHA (see Fig. 2 and Table 1 ). These results indicate that DNA-PKin the nuclear extracts increased from 36 to 48 h after the stimulation of T cell growth, at which time a large population of the activated T cells entered into S phase and subsequently into G2/M phase ( Fig. IB and C) .
Correlation of nuclear DNA-PK activity with cellproliferation.
To further investigate the relation between DNA-PK activity in the nuclear extracts and cell proliferation, efficient inhibitors that arrest cell proliferation were employed. Cyclosporin is an immunosuppressant inhibiting IL-2 production in T cells and subsequently T cell proliferation. Addition of cyclosporin to PHA-stimulated PBMCresulted in suppression of DNA-PKactivity as well as of [3H]thymidine incorporation (Table I) . WhenPDB/ionomycin-stimulated T cells were treated with aphidicolin, an inhibitor of DNApolymerases a/d/e, which blocks the cell cycle at the Gl/S boundary, neither significant increase in DNA-PKactivity nor increase in [3H]thymidine incorporation into DNAwas detected at 48 h after stimulation (Table I ). In the presence of demecolcine, which blocks the G2/M transition and then prevents T cells from entering into the second cell cycle, DNA-PKactivity was as high as the con- trol PDB/ionomycin-activated T cells 48 h after stimulation, and decreased from 58 to 72 h after stimulation (Table I and (7), and the partially purified DNA-PK(10 fig) was treated in the same way as crude nuclear extracts (lane 4). Immunoprecipitation with mouse anti (DNA-PKcs) antibody was carried out as described in Materials and Methods, and the immunocomplex containing DNA-PKholoenzyme was incubated in the reaction mixture without exogenous substrate, followed by SDS-7.5%polyacrylamide gel electrophoresis. DNA-PKcs was visualized as protein bands stained with silver (silver) and in an autoradiogram (32P).
T cells treated with cyclosporin, aphidicolin, or demecolcine was comparable to that of untreated T cells during the culture. These results imply that the level of nuclear DNA-PKactivity of T lymphocytes is closely correlated with cell proliferation.
Immunopredpitation of nuclear DNA-PKcs. DNA-PKis composed of DNA-PKcs(p470) and Ku protein (p70/p80), of which the former alone has a low kinase activity even in the presence of DNA(7, 10-13).
To detect directly DNA-PKcs in the nuclear extracts, DNA-PKcs was immunoprecipitated with mouseanti (DNA-PKcs) antibody in the presence of exogenous DNA. The antibody reacts with DNA-PKcsalone and DNA-PK holoenzyme (DNA-PKcs/Ku/DNA) without affecting the enzyme activity (15). The immunocomplex bound to protein G-agarose was autophosphorylated in a DNA-PK reaction mixture without exogenous substrate. After SDS-polyacrylamide gel electrophoresis, DNA-PKcs was visualized by silver staining and by autoradiography (Fig. 3) . In T cells 48 h after treatment with PHA, the silver-stained band and the 32P band of DNAPKcs were observed, whereas they were hardly detectable in resting and cyclosporin-treated T cells. These results imply that up-regulation of nuclear DNA-PKis ascribable to an increase in the amount of active DNAPKcs.
DNA-PK activity in the whole cell extracts. When DNA-PKactivity in T lymphocytes was determined with the whole cell extracts instead of the nuclear extracts, full activity of DNA-PKwas detected in resting T cells.
Similar results were obtained with PBMC or T lymphocytes from more than ten healthy volunteers (data not shown). So we reexamined the relationship between DNA-PK in normal human T lymphocytes and the cell proliferation.
As shown in Fig. 4 , DNA-PK activity in the whole cell extracts from T lymphocytes was essentially constant after treatment with PHA, suggesting the extranuclear localization of DNA-PKcs in resting PBMC. Western blot analysis of DNA-PK. To analyze the protein level of DNA-PKcsand Ku in the nuclear and whole cell extracts, Western blotting/enzyme immunoassay was employed. The level of DNAPKcs in the nuclear extracts from resting PBMCwas very low compared with that in the whole cell extracts, and 48 h after PHAtreatment the nuclear DNA-PKcs level was apparently comparable to that in the whole cell extracts (Fig. 5 ). In contrast, the level of nuclear Ku protein, like Ku protein level in the whole cell extracts, did not differ greatly between the resting and growing states of T lymphocytes (Fig. 5) . This is consistent with the observation that only 2-to 3-fold induction of Ku protein (p80/p70) was observed 72 h after stimulation with PHAin normal human T cells (31) . These results indicate that up-regulation of nuclear DNA-PKis due to an increase in DNA-PKcslevel, and suggest that DNA-PKcsin PBMCtranslocates from the cytoplasm to the nucleus after stimulation of cell growth.
Immunocytochemical detection ofDNA-PK in PBMC.
To verify directly the translocation of DNA-PKcs from the cytoplasm to the nucleus, we examined the immunofluorescence localization of DNA-PKcsand Ku protein in PBMC.Consistent with the results of immunoblot analysis, DNA-PKcs was hardly detectable in the nucleus of quiescent PBMC but was present in the cytoplasmic region (Fig. 6A) . Immunofluorescence of DNA-PKcswas detected in the nucleus 48 h after PHA stimulation (Fig. 6B) . Ku protein was always localized in the nucleus (Fig. 6C and D) . These results suggest that DNA-PKcspresent in the cytoplasm in resting T lymphocytes translocates into the nucleus when activated with mitogens.
DISCUSSION
Immunoblot and immunofluorescence analyses revealed that DNA-PKcsin quiescent lymphocytes from normal humanblood is present in the cytoplasmic region rather than in the nucleus and that growth stimulation results in translocation of DNA-PKcs from the cytoplasm to the nucleus. The regulatory component Ku protein is virtually all localized in the nucleus in quiescent as well as proliferating lymphocytes. In contrast to normal human lymphocytes, almost all DNA-PK activity was detected in the nuclear fraction of Raji (32) . When DNA-PKcsin quiescent lymphocytes is pre- At the resting stage of normal human T lymphocytes, DNA-PKcs was virtually distributed in the cytoplasmic region, while DNA-PKactivity in the nuclear extracts was low. DNA-PKcs appeared in the nucleus concomitant with a drastic increase in nuclear DNA-PKactivity 48 h after the stimulation of T cell proliferation with PHAor PDB/ionomycin. At 36 h after stimulation, at which time T lymphocytes seem to enter into S phase (see Fig. 1 (Fig. 1) . On addition of aphidicolin, which blocks the cell cycle at the Gl/S boundary, DNA-PKactivity was not significantly observed after the stimulation. These observations imply that the translocation of DNA-PKcsinto the nucleus is associated with the proliferative state of T lymphocytes. Expression of IL-2 receptor also increased dramatically from 48 to 72 h after stimulation (data not shown). IL-2 receptor a subunit has been reported to be up-regulated by IL-2 produced by T cells autocrinely or paracrinely. As was predicted, addition of cyclosporin, which inhibits IL-2 production in T cells, suppressed not only cell proliferation but also the increase in nuclear DNA-PKactivity (Table I ). The experiment with demecolcine exhibited the close relationship between nuclear DNA-PK activity and cell proliferation more clearly. Demecolcine-treated T cells were capable of entering into S phase and exhibited DNA-PKactivity as high as the nontreated cells at 48 h.
From 58 to 72h after stimulation with PDB/ionomycin, the nuclear activity decreased in demecolcinetreated T cells, which were not able to pass through the G2/Mphase to enter into the second cell cycle. Nuclear DNA-PKactivity may be down-regulated in all phases except the S phase in T lymphocytes.
The DNA-PKregulatory component Ku protein (p70/p80) is an abundant nuclear protein that is well known as an autoimmune antigen (12). Ku protein in T lymphocytes did not change either in its subcellular distribution observed by immunofluorescence (see Fig. 6 ) or in the amount of the protein estimated by Western blotting (see Fig. 5 ). Previously, the Ku protein level was reported to increase maximally by 2-to 3-fold at 72 h in humanPHA-stimulated lymphocytes whenequal numbersof stimulated and non-stimulated cells were analyzed (31) . This minor discrepancy may be due to the fact that we analyzed equal amounts of protein instead of equal numbers of cell. Nuclear DNA-PK activity seems to be regulated by the amount of nuclear DNAPKcs at least during the cell cycle progression of normal human T cells. Weclearly showed that nuclear DNA-PK activity is well correlated with the amount of DNAPKcs and the autophosphorylation of DNA-PKcs determined with the holoenzyme immunoprecipitated in the presence of DNA(see Fig. 3 ). DNA-PKactivity is likely to be regulated by autophosphorylation of DNA-PKcs (22) .
In addition, DNA-PKcs was observed to be cleaved to a limited degradation product of about 200 kDa in several types of humancells (data not shown), and DNA-PKcs is known as a death substrate in the apoptotic process (35) (36) (37) (38) 
